FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Company Type

Goods Manufacturer

Industries

  • Petroleum ‎1
    • Exploration ‎1

Contact Info

Location

Sartorius

  • 1Product
  • 1Types
  • 1Industry

About Company

Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Hundreds of millions of people lack access to affordable and safe medicines. Our biopharma customers are working hard to develop new drugs to improve people's lives. The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry, listed on the German DAX and TecDAX stock markets. In fiscal 2020, the company recorded

Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Hundreds of millions of people lack access to affordable and safe medicines. Our biopharma customers are working hard to develop new drugs to improve people's lives. The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry, listed on the German DAX and TecDAX stock markets. In fiscal 2020, the company recorded sales of €2.34 billion, growing by around 30%. Our ambition is to simplify progress in biopharmaceutical research and production. We support our customers with innovative technologies that make the development and manufacture of innovative therapeutics faster and more efficient. So that more people have access to better medicine. Nearly 11,000 employees at over 60 production and sales locations worldwide are committed to this vision. As one of the fasted-growing global life science companies, we are looking for people who share our ambition and want to make a contribution in a vibrant environment while growing their careers.Join our global team and grow with us.www.sartorius.com/jobs

Products

Sartobind® Q Nano 1 mL, 4 mm bed height, 4 units

PETROLEUM - EXPLORATION   |  ADSORBENT

Sartobind® Q Nano 1 mL, 4 mm bed height, 4 units

Analytical Reports